Details Basic Details Status Ongoing Last Updated Friday, November 1, 2024 Original Posting Date Tuesday, September 17, 2024 Health Outcome(s) signal identification Purpose Signal Identification Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Result(s) (2) Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis